www.verygoodnewsisrael.blogspot.com
ISRAEL’S MEDICAL ACHIEVEMENTS
Revolutionary technology to review ultrasound scans. Israeli startup iNNOGING enables physicians to manipulate ultrasound video captured previously by a technician and perform a virtual dynamic exam without the patient being present. The original scan’s video clips are converted into a 3D model of the examined area.
https://www.israel21c.org/breakthrough-system-turns-ultrasound-images-into-virtual-3d-models/
https://innoging.com/technology/
Breakthrough treatment for urinary tract cancer. (TY Atid-EDI) I reported previously (May 2017) that Israel’s UroGen had been granted FDA’s Orphan status for its treatment of malignant Upper Tract Urothelial Carcinoma. It has now received Breakthrough Therapy Designation status to help speed up development.
http://investors.urogen.com/phoenix.zhtml?c=254372&p=irol-newsArticle&ID=2374119
Device to cure both overeating and sleep apnea. Zen Eating, with R&D in Israel, has developed the Sipper – a device that trains the tongue to digest food slower, to match the brain’s “I’m full” mechanism. A Sipper user eats up to 30% less food per meal. The training also can cure snoring – a major cause of sleep apnea.
https://www.timesofisrael.com/obesity-sleep-apnea-are-targeted-by-new-straw/ https://zeneating.com/
https://www.youtube.com/watch?v=z2V_gHub1A0https://www.youtube.com/embed/xLMsTp9oaRg?rel=0
3D-printed lung transplants. (TY Atid-EDI) Israel’s CollPlant has licensed US’s United Therapeutics to use CollPlant’s 3D bio-printing technology to manufacture lung transplants. The multi-million-dollar agreement can be expanded to print up to three additional organs. CollPlant will initially supply the necessary bio-ink
https://ir.collplant.com/press-releases/detail/54/collplant-and-united-therapeutics-announce-global-licensing
Trials to regrow knee cartilage. (TY Atid-EDI) I reported previously (Nov 2016) that Israel’s Regentis was to begin Phase III trials on its GelrinC, treatment for cartilage damage in the knee. The study has now been extended to 11 US sites involving 120 patients. The GelrinC implant encourages stem cells to re-grow cartilage.
https://www.businesswire.com/news/home/20181023005469/en/Regentis-Biomaterials-Expands-SAGE-Clinical-Trial-GelrinC%E2%84%A2
Intensive care system in use. (TY Atid-EDI) I reported previously (see here)about Israel’s Clew Medical and its system to warn of deteriorating Intensive Care Unit (ICU) patients. It has since been trialed at Tel Aviv’s Ichilov Hospital and several US hospitals and is to be used at Tel Hashomer’s Sheba Medical Center.
https://en.globes.co.il/en/article-israeli-clinical-analytics-co-clew-raising-20m-1001257452
The hospital of the future. Israel’s Sheba Medical Center hosted a summit “The Future Hospital: Setting Strategies for 2030 and Beyond”. Healthcare leaders and innovators from the USA, Canada, UK, EU and Israel discussed challenges facing hospitals and saw Israeli cutting-edge technologies shaping the future of medicine.
http://www.jewishpress.com/news/health-and-medicine/sheba-medical-center/sheba-medical-center-international-summit-attracts-top-american-hospital-and-healthcare-execs/2018/10/30/
Israeli support for Pittsburgh. Volunteers from Israel’s ZAKA Search & Rescue, Dream Doctors and the Psycho-trauma and Crisis Response Unit of Israel’s United Hatzalah have arrived in Pittsburgh to provide aid to the community and the victims of the deadly mass shooting at the Tree of Life synagogue.
https://www.jpost.com/Diaspora/Israeli-psychotrauma-team-en-route-to-Pittsburgh-to-aid-terror-victims-570493 https://www.israel21c.org/israeli-experts-on-scene-in-wake-of-pittsburgh-shooting/